Emergency contraception in Spain

Levonorgestrel is used as an emergency contraceptive pill.

Emergency contraception in Spain refers to the contraceptive methods used in Spain that prevent a fertilized egg from implanting in the uterus. These include the morning-after pill and levonorgestrel. The situation in Spain is unique due to its history of access to contraception in general, the legislative timeline that legalized emergency contraception and under what conditions it could be dispensed, the impact of conscientious objection by doctors and pharmacists, cases in the Spanish judiciary related to conscientious objection, the relatively high cost compared to other countries in Europe and North America, the linkage of emergency contraception with efforts to reduce abortions by both left-wing and right-wing political parties, the impact of the COVID-19 pandemic on the distribution of emergency contraceptives, and usage statistics.

Article 149.1.16 of the Spanish Constitution grants the national government the exclusive right to regulate pharmaceutical products in Spain. Law 29/2006 grants the Spanish Agency of Medicines and Medical Devices (AEMPS) the right to modify conditions relating to prescription and dispensing for reasons related to public health or the defense of health. The distribution of the Emergency Contraceptive Pill (PAU) was authorized by the government led by José María Aznar's Popular Party on 23 March 2001 and its distribution began in May 2001. Policies regarding the use of emergency contraception in public healthcare were left to regional governments, resulting in different policies and levels of access across the country. These differences were clear in 2008. For this reason, in May 2009 the Spanish Government authorized the over-the-counter distribution of ECP-LNG to facilitate women's access to the drug and guarantee its effectiveness regardless of their place of residence, initiating its distribution in pharmacies without a prescription from September of that year. Spain's 2022 reproductive health law, Organic Law 4/2022, also changed how women could access emergency contraception in an effort to decrease abortions and create equitable access across the country. For the first time, national legislation ruled that the pill would be funded by the Ministry of Health, and would be provided free of charge in health centers throughout the country, requiring pharmacies to have emergency contraceptives in their inventories.

Chemical structural formula of the Ulipristal Acetate (EllaOne)

Norlevo and Postinor, the emergency contraceptive drugs with levonorgestrel as the active ingredient, were the brands authorized to sell the morning-after pill in Spain from May 2001. EllaOne, with the active ingredient ulipristal acetate (UPA), was approved for use in Spain in December 2009 and was sold as a 30 mg tablet at a cost of €32.78. Between 2001 and 2011, Spain recorded thirty-five adverse reactions and twenty serious adverse reactions in women using emergency contraception. The AEMPS reported in 2012 that the most common side effects of taking levonorgestrel were nausea, headache, dizziness, fatigue, gastrointestinal pain, bleeding, delayed menstruation, heavy menstruation, and increased breast tenderness. There are a number of laws governing the rights of minors related to access to emergency contraception. There are also national laws regarding what medications pharmacies must have in their inventory.

Women throughout Spain have sometimes had problems accessing emergency contraception. Sometimes hospitals had internal policies that denied women access to prescriptions for the morning-after pill. Some hospital doctors were conscientious objectors. Some pharmacies refused to sell it and some pharmacists were conscientious objectors. There were doctors who were reluctant to prescribe it to minors, despite the fact that they could legally do so without a guardian's permission. Many health centers in rural areas were closed on weekends or were not open 24 hours a day. There were women who also faced problems because their doctors required them to have a pregnancy test before administering emergency contraception. The requirement for a medical prescription made access difficult for many women. When it became available over the counter in pharmacies, the cost was often an issue.